8-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

______________

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

______________

Date of Report (Date of earliest event reported):   November 14, 2002

ORCHID BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)

Delaware	000-30267	22-3392819
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

4390 US ROUTE ONE, PRINCETON, NJ	08540
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code:   (609) 750-2200

Item 7.    Financial Statements and Exhibits

(c) Exhibits.

Exhibit No.	Description
99.1	Certification of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Item 9.    Regulation FD Disclosure

In connection with the Quarterly Report on Form 10-Q of Orchid BioSciences, Inc. (the “Company”) for the quarter ended September 30, 2002, as filed with the Securities and Exchange Commission concurrently herewith, the Company hereby furnishes the written statement of the Company’s principal executive officer and principal financial officer required by Section 906 of the Sarbanes-Oxley Act of 2002. On November 14, 2002, Dale R. Pfost, President and Chief Executive Officer of the Company, and Andrew P. Savadelis, Senior Vice President and Chief Financial Officer of the Company, each executed this written statement. A copy of the foregoing written statement is attached hereto as exhibit 99.1 and incorporated herein by reference.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ORCHID BIOSCIENCES, INC.
	(Registrant)
Date: November 14, 2002	By:	/s/Andrew P. Savadelis
		Andrew P. Savadelis
		Senior Vice President and Chief Financial
		Officer

3

EXHIBIT INDEX

Exhibit No.	Description
99.1	Certification of principal executive officer and principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

EX-99.1

Exhibit 99.1

Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, Unites States Code), each of the undersigned officers of Orchid BioSciences, Inc., (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2002 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: November 14, 2002	/s/ Dale R. Pfost
	Dale R. Pfost, PhD., President and       Chief Executive Officer
Dated: November 14, 2002	/s/ Andrew P. Savadelis
	Andrew P. Savadelis, Senior Vice President       and Chief Financial Officer

The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Codes) and is not being filed as part of a separate disclosure document.